465 related articles for article (PubMed ID: 12794302)
21. Alpha-synuclein aggregation and neurodegenerative diseases.
Ma QL; Chan P; Yoshii M; Uéda K
J Alzheimers Dis; 2003 Apr; 5(2):139-48. PubMed ID: 12719631
[TBL] [Abstract][Full Text] [Related]
22. Plaque-associated alpha-synuclein (NACP) pathology in aged transgenic mice expressing amyloid precursor protein.
Yang F; Uéda K; Chen P; Ashe KH; Cole GM
Brain Res; 2000 Jan; 853(2):381-3. PubMed ID: 10640638
[TBL] [Abstract][Full Text] [Related]
23. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases.
Hashimoto M; Rockenstein E; Crews L; Masliah E
Neuromolecular Med; 2003; 4(1-2):21-36. PubMed ID: 14528050
[TBL] [Abstract][Full Text] [Related]
24. The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease.
Clayton DF; George JM
Trends Neurosci; 1998 Jun; 21(6):249-54. PubMed ID: 9641537
[TBL] [Abstract][Full Text] [Related]
25. Synphilin isoforms and the search for a cellular model of lewy body formation in Parkinson's disease.
Eyal A; Engelender S
Cell Cycle; 2006 Sep; 5(18):2082-6. PubMed ID: 16969096
[TBL] [Abstract][Full Text] [Related]
26. Rat alpha-synuclein interacts with Tat binding protein 1, a component of the 26S proteasomal complex.
Ghee M; Fournier A; Mallet J
J Neurochem; 2000 Nov; 75(5):2221-4. PubMed ID: 11032911
[TBL] [Abstract][Full Text] [Related]
27. alpha-Synuclein is phosphorylated in synucleinopathy lesions.
Fujiwara H; Hasegawa M; Dohmae N; Kawashima A; Masliah E; Goldberg MS; Shen J; Takio K; Iwatsubo T
Nat Cell Biol; 2002 Feb; 4(2):160-4. PubMed ID: 11813001
[TBL] [Abstract][Full Text] [Related]
28. Interactions of amyloidogenic proteins.
Giasson BI; Lee VM; Trojanowski JQ
Neuromolecular Med; 2003; 4(1-2):49-58. PubMed ID: 14528052
[TBL] [Abstract][Full Text] [Related]
29. Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders.
Takeda A; Mallory M; Sundsmo M; Honer W; Hansen L; Masliah E
Am J Pathol; 1998 Feb; 152(2):367-72. PubMed ID: 9466562
[TBL] [Abstract][Full Text] [Related]
30. C-terminal alpha-synuclein immunoreactivity in structures other than Lewy bodies in neurodegenerative disorders.
Takeda A; Hashimoto M; Mallory M; Sundsumo M; Hansen L; Masliah E
Acta Neuropathol; 2000 Mar; 99(3):296-304. PubMed ID: 10663973
[TBL] [Abstract][Full Text] [Related]
31. Degradative organelles containing mislocalized alpha-and beta-synuclein proliferate in presenilin-1 null neurons.
Wilson CA; Murphy DD; Giasson BI; Zhang B; Trojanowski JQ; Lee VM
J Cell Biol; 2004 May; 165(3):335-46. PubMed ID: 15123735
[TBL] [Abstract][Full Text] [Related]
32. Role of oxidative damage in protein aggregation associated with Parkinson's disease and related disorders.
Norris EH; Giasson BI
Antioxid Redox Signal; 2005; 7(5-6):672-84. PubMed ID: 15890012
[TBL] [Abstract][Full Text] [Related]
33. Distinctive neuropathology revealed by alpha-synuclein antibodies in hereditary parkinsonism and dementia linked to chromosome 4p.
Gwinn-Hardy K; Mehta ND; Farrer M; Maraganore D; Muenter M; Yen SH; Hardy J; Dickson DW
Acta Neuropathol; 2000 Jun; 99(6):663-72. PubMed ID: 10867800
[TBL] [Abstract][Full Text] [Related]
34. Immunocytochemical localization of synphilin-1, an alpha-synuclein-associated protein, in neurodegenerative disorders.
Wakabayashi K; Engelender S; Tanaka Y; Yoshimoto M; Mori F; Tsuji S; Ross CA; Takahashi H
Acta Neuropathol; 2002 Mar; 103(3):209-14. PubMed ID: 11907799
[TBL] [Abstract][Full Text] [Related]
35. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.
Baba M; Nakajo S; Tu PH; Tomita T; Nakaya K; Lee VM; Trojanowski JQ; Iwatsubo T
Am J Pathol; 1998 Apr; 152(4):879-84. PubMed ID: 9546347
[TBL] [Abstract][Full Text] [Related]
36. Lewy body variant of Alzheimer's disease: alpha-synuclein in dystrophic neurites of A beta plaques.
Wirths O; Weickert S; Majtenyi K; Havas L; Kahle PJ; Okochi M; Haass C; Multhaup G; Beyreuther K; Bayer TA
Neuroreport; 2000 Nov; 11(17):3737-41. PubMed ID: 11117482
[TBL] [Abstract][Full Text] [Related]
37. Multiplication of the alpha-synuclein gene is not a common disease mechanism in Lewy body disease.
Lockhart PJ; Kachergus J; Lincoln S; Hulihan M; Bisceglio G; Thomas N; Dickson D; Farrer MJ
J Mol Neurosci; 2004; 24(3):337-42. PubMed ID: 15655258
[TBL] [Abstract][Full Text] [Related]
38. Mutation in the alpha-synuclein gene and sporadic Parkinson's disease, Alzheimer's disease, and dementia with lewy bodies.
Higuchi S; Arai H; Matsushita S; Matsui T; Kimpara T; Takeda A; Shirakura K
Exp Neurol; 1998 Sep; 153(1):164-6. PubMed ID: 9743579
[TBL] [Abstract][Full Text] [Related]
39. The role of alpha-synuclein in neurodegenerative diseases.
Bennett MC
Pharmacol Ther; 2005 Mar; 105(3):311-31. PubMed ID: 15737408
[TBL] [Abstract][Full Text] [Related]
40. Alpha-synuclein and neurodegenerative diseases.
Goedert M
Nat Rev Neurosci; 2001 Jul; 2(7):492-501. PubMed ID: 11433374
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
